Related Experiment Video
Updated: May 15, 2026
Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
Targeted prostate cancer ablation: energy options
Jonathan A Coleman1, Peter T Scardino
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. colemanj@mskcc.org
Purpose Of Review:
Prostate cancer screening practices are providing new opportunities for earlier diagnosis, and for identifying smaller tumours with low probability of regional involvement and high likelihood of curability. Simultaneous innovations in tissue ablation technologies offer the potential for effective targeted treatments to discrete areas within the prostate, with negligible side-effects. This review provides an overview of recent data on developing options for prostate cancer ablation, the mechanisms of action of these modalities and results to date of these treatments.
Recent Findings:
Advances in diagnostic imaging and image-guided biopsy techniques hold the promise of more accurate localization of cancers within the prostate and a shift in the field of prostate cancer treatment towards an interest in less invasive, localized treatment options. Several energy ablative technologies, currently being tested in clinical trials, are likely to play a greater role in the treatment of patients with smaller, earlier stage tumours.
Summary:
Although none of the advances in cancer detection, targeted imaging or focal treatment have yet proven to be game-changing, together, they have contributed to a movement towards less invasive, focal treatment for prostate cancer and a growing awareness of the potential clinical benefits of this form of therapy.
Insights
Early prostate cancer detection and innovative ablation technologies are enabling less invasive, localized treatments. This shift offers potential for highly effective therapies with minimal side effects for early-stage tumors.
Area of Science:
- Oncology
- Medical Technology
- Urology
Background:
- Prostate cancer screening advances enable earlier diagnosis of smaller, more curable tumors.
- Innovations in tissue ablation technologies offer targeted treatment options with reduced side effects.
Purpose of the Study:
- To review emerging prostate cancer ablation options.
- To discuss the mechanisms of action for these modalities.
- To present current treatment results.
Main Methods:
- Review of recent data on developing prostate cancer ablation technologies.
- Analysis of mechanisms of action for various ablative modalities.
- Evaluation of clinical trial results for focal treatments.
Main Results:
- Advances in diagnostic imaging and image-guided biopsy improve cancer localization.
- Energy ablative technologies are being tested for treating smaller, earlier-stage prostate tumors.
- These technologies show promise for less invasive, localized treatment options.
Conclusions:
- While no single advance is yet 'game-changing,' combined progress supports a move towards less invasive, focal prostate cancer treatment.
- There is a growing recognition of the clinical benefits of focal therapy for prostate cancer.
- The integration of detection, imaging, and focal treatment is reshaping prostate cancer management.
